🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalGerman Krankenkasse coverage for GLP-1 — Adipositas-Programm

German Krankenkasse coverage for GLP-1 — Adipositas-Programm

amsterdam_pete Fri, Jun 5, 2026 at 7:18 PM 2 replies 148 viewsPage 1 of 1
amsterdam_pete
Senior Member
1,567
6,789
Feb 2024
Netherlands
Jun 5, 2026 at 7:18 PM#1

The list price and the price I actually pay differ by a factor of six depending on which of four routes I use, and none of that is transparent from the outside.

The narrow version of the question is what actually works on a prior-authorisation denial, as opposed to the list of things that sound like they should work.

Practical detail welcome, however dull — the duller the better.

40 10JakeSmashed95, NauseaFreeNow, SteveThurs and 37 others
Reply Quote Save Share Report
kate.chem
VIP Member
3,890
17,654
Dec 2023
California
Jun 5, 2026 at 7:25 PM#2
amsterdam_pete said:
The list price and the price I actually pay differ by a factor of six depending on which of four routes I use, and none of that is transparent from…

Insurance coverage hack for cost and coverage: if your insurance denies brand Wegovy/Ozempic, consider these alternatives:

  1. Prior authorization appeal with peer-to-peer review
  2. Manufacturer copay card (for commercial insurance)
  3. Patient assistance programs (Novo Nordisk, Eli Lilly)
  4. Compounded medication from a 503B pharmacy ($107/month)
  5. Canadian pharmacy (requires prescription, ~40-60% savings)

Don't let cost prevent access to effective treatment. There are options at every price point.

39 9VanRx_Mike, steve_okc, dave_SLC and 36 others
Reply Quote Save Share Report
COA_Karl
Senior Member
2,123
8,901
Jan 2024
Pennsylvania
Jun 5, 2026 at 7:32 PM#3
kate.chem said:
Insurance coverage hack for cost and coverage: if your insurance denies brand Wegovy/Ozempic, consider these alternatives: Prior authorization appeal…
kate.chem said:
...compounded vs brand cost and coverage...

This debate comes up weekly and I think both sides have valid points:

Pro-brand: FDA-approved, manufacturing standards guaranteed, clinical trial data directly applicable

Pro-compounded: 10x cost savings, same active molecule, independent testing available, accessibility

My position: if you can afford brand or have insurance coverage, that's the gold standard. If not, properly tested compounded from a 503B pharmacy is a reasonable alternative. Neither side should shame the other.

38 8hyun_seoul, jim_asheville, matt_MKE and 35 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
CanadaChris
Member
234
890
Nov 2024
Toronto, CA
Jun 5, 2026 at 7:39 PM#4
amsterdam_pete said:
The list price and the price I actually pay differ by a factor of six depending on which of four routes I use, and none of that is transparent from…

Mine went the same way, slower.

37 7Dr.PulmRoch, maya_sedona, stefan_berlin and 34 others
Reply Quote Save Share Report
Dr.AddMedPHL
Senior Member
1,234
6,234
Mar 2024
Philadelphia, PA
Jun 5, 2026 at 8:12 PM#5

From the other side of the consultation, briefly.

Insurance update relevant to cost and coverage: I just got my prior auth approved through Aetna after 1 attempts.

What finally worked: a letter from my endocrinologist documenting BMI history (>3 years), failed diet attempts, comorbidities (PCOS + insulin resistance), and referencing the SELECT trial data.

If your PA keeps getting denied, don't give up. Request a peer-to-peer review between your doctor and the insurance medical director. That's what finally broke through for me.

Last edited: Jun 5, 2026 at 10:12 PM
36 6JessicaM_2024, TomFromTexas, mike.trainer_LA and 33 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register